Apple dropped a bombshell with its new FDA-cleared ECG feature on the Watch, rousing huge excitement. (Study data here.) The highly produced announcement was perfectly timed with its FDA clearance, raising eyebrows about an unprecedented level of coziness with government. But folks like Dr. Eric Topol gave Apple flak for claiming its technology is groundbreaking. AliveCor's CEO (a former Googler) even accused Apple of making up alternative facts. "We’ve been doing this for seven years." AliveCor saw sales skyrocket for its $99 ECG smartphone hardware following Apple's news. Regardless, it’s a strong marker of Apple’s interest—and the big money tech sees—in healthcare.
We’re getting smart about big tech's bets at our Summit next month. Catch the conversation with former Cleveland Clinic CEO-turned-Googler Toby Cosgrove and CNBC’s Chrissy Farr. Save your seat—or sponsor.
Apple's ECG Announcement Years In The Making, But Its Timing Was Remarkable
Eyebrows were raised for all sorts of reasons | MobiHealthNews
Six Reasons We Can't Wait For Rock Health Summit
Our seventh annual event is one month away | Rock Health
Connecting Your Medical Data Could Be The Next Big Payoff
The silos that hold medical records are beginning to crumble. Medicare could speed it up | Politico
FDA Roundup: The Major Device, App, And Algorithm Approvals Of 2018 (So Far)
Most are getting cleared through 510(k) and de novo pathways | MobiHealthNews
UHC CEO: Digital Health Will Soon Be Synonymous With Health
We couldn't agree more | Business Insider
Are We Being Misled About Precision Medicine?
Deaths still vastly outnumber the rare successes | The New York Times
Omada's Tech Put It On The Map. Now It's Luring Insurers With Operational Innovation
Staffers joke that the company is a "provendor" | FierceHealthcare
- Connected cardiac monitor maker InfoBionic received $50M
- Endotronix raised $45M for its technology to help monitor and fight cardiovascular issues
- Mirror raised $25M and launched its in-home fitness platform and massive LCD panel
- NY-based Wellth closed $5.1M to help patients adhere to their care plans
- Diabetes coaching platform Fit4D landed $4M